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BACKGROUND 
• Colorectal cancer (CRC) screening has been proven to be a 
feasible, cost-effective way to reduce incidence of and 
mortality from CRC. 
• CRC is the second-leading cause of cancer-related death in 
the United States.  
• As early CRC is asymptomatic, it is imperative that we detect 
it early to reduce mortality.  
• Despite the widespread availability of CRC screening, CRC 
screening rates in our ambulatory sites have been below 
average.  
• The Wednesday Jefferson Hospital Ambulatory Practice 
(JHAP) resident clinic’s CRC screening rate was 44.3% in 
September 2016 as compared to an average of 57% at other 
ambulatory sites in the Greater Philadelphia region. 
Therefore, CRC screening was targeted as an area of quality 
improvement.  
• Our goals were to implement an intervention to improve 
CRC screening rates in our practice as well as identify site-
specific obstacles to CRC screening that could be intervened 
on in the future. 
• Fecal Immunochemical Test (FIT) is a FDA approved CRC 
screening modality for one year. 
AIM STATEMENT 
Our aim at Wednesday JHAP was to increase the rate of 
colorectal cancer screenings from 44.3% to 60% from 
September 2o16 to May 2017 (9 months) 
INTERVENTION 
• Our primary intervention was to offer GI referral for colonoscopy, 
and for  patients who refused screening colonoscopy, FIT was 
offered as an alternative.  
• A secondary intervention was educating residents about the 
importance of colon cancer screening, how to discuss colon cancer 
screening options with their patients, and how to teach their 
patients to properly use FIT kits.  
• In November 2016, resident physicians started calling patients who 
were due for CRC screening to arrange CRC screening. Reasons for 
patient noncompliance or nonadherence were documented.  
• Then, since February 2017, patients who still required CRC 
screening were again contacted via phone and/or mail to set up CRC 
screening. 
RESULTS 
DISCUSSION 
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• Despite not reaching our AIM, we were able to increase our 
colon cancer screening rate by 16% from 9/2016 to 5/2017 
• The most common barrier to colon cancer screening  
reported was difficulty scheduling a colonoscopy. Future 
steps include collaborating with GI to develop a more 
efficient and effective colonoscopy scheduling system and 
having multiple resident education sessions to train 
residents on how to effectively educate patients about FIT as 
an alternative CRC screening option. 
• The second most common barrier identified by patients was 
fear of colonoscopy. We hoped that offering FIT testing 
would be a suitable alternative for these patients. A future 
direction is a handout for patients addressing common 
patient concerns regarding colonoscopy and providing 
further information to allow for greater patient education 
and reassurance.  
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